Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankaj Kumar Singh

Showing results (1-10 of 318) with videos related to

Pageof 32
Sort By:
Cureus|February 17, 2025
Effect of Intravascular Ultrasonography (IVUS) Imaging on Stent Optimization in Patients Achieving Optimal Results After Angiographic-Guided Stent Implantation: A Non-randomized Interventional StudyPankaj Kumar Singh
European Journal of Medicinal Chemistry|February 9, 2019
Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferationPankaj Kumar Singh
Chemmedchem|April 1, 2018
The Current Status of O-Heterocycles: A Synthetic and Medicinal OverviewPankaj Kumar Singh, Om Silakari
Journal of Biomolecular Structure & Dynamics|July 27, 2018
In silico guided development of imine-based inhibitors for resistance-deriving kinasesPankaj Kumar Singh, Om Silakari
Bioorganic Chemistry|May 15, 2018
Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-METPankaj Kumar Singh, Om Silakari
The Journal of the Association of Physicians of India|January 26, 2020
Correlation Study of Apolipoprotein'a' with Diabetic Retinopathy in Patients of Type 2 Diabetes Mellitus with RetinopathyPankaj Kumar Singh, Ravi Tandon
Life Sciences|August 8, 2017
Chemotherapeutics-resistance "arms" race: An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancerPankaj Kumar Singh, Om Silakari
Journal of Molecular Modeling|October 22, 2018
Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancerPankaj Kumar Singh, Om Silakari
Future Medicinal Chemistry|April 1, 2017
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancerPankaj Kumar Singh, Om Silakari
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2020
Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?Shelly Pathania, Pankaj Kumar Singh
Pageof 32

Showing results (1-10 of 318) with videos related to

Sort By:
Pageof 32
Cureus|February 17, 2025
Effect of Intravascular Ultrasonography (IVUS) Imaging on Stent Optimization in Patients Achieving Optimal Results After Angiographic-Guided Stent Implantation: A Non-randomized Interventional StudyPankaj Kumar Singh
European Journal of Medicinal Chemistry|February 9, 2019
Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferationPankaj Kumar Singh
Chemmedchem|April 1, 2018
The Current Status of O-Heterocycles: A Synthetic and Medicinal OverviewPankaj Kumar Singh, Om Silakari
Journal of Biomolecular Structure & Dynamics|July 27, 2018
In silico guided development of imine-based inhibitors for resistance-deriving kinasesPankaj Kumar Singh, Om Silakari
Bioorganic Chemistry|May 15, 2018
Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-METPankaj Kumar Singh, Om Silakari
The Journal of the Association of Physicians of India|January 26, 2020
Correlation Study of Apolipoprotein'a' with Diabetic Retinopathy in Patients of Type 2 Diabetes Mellitus with RetinopathyPankaj Kumar Singh, Ravi Tandon
Life Sciences|August 8, 2017
Chemotherapeutics-resistance "arms" race: An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancerPankaj Kumar Singh, Om Silakari
Journal of Molecular Modeling|October 22, 2018
Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancerPankaj Kumar Singh, Om Silakari
Future Medicinal Chemistry|April 1, 2017
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancerPankaj Kumar Singh, Om Silakari
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2020
Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?Shelly Pathania, Pankaj Kumar Singh
Pageof 32